Top

Published in:

01-12-2020 | Alzheimer's Disease | Original Paper

5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice

Authors: Bhupesh Chandra Semwal, Debapriya Garabadu

Published in: NeuroMolecular Medicine | Issue 4/2020

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with loss in memory as one of the cardinal features. 5-N-ethyl carboxamidoadenosine (NECA), an agonist of adenosine-2b receptor, exerts neuroprotective activity against several experimental conditions. Further, NECA activates mitogen-activated protein kinase (MAPK) and also attenuates mitochondrial toxicity in mammalian tissues other than brain. Moreover, there is no report on the role of A2b/MAPK-mediated signaling pathway in Aβ-induced mitochondrial toxicity in the brain of the experimental animals. Therefore, the present study evaluated the neuroprotective activity of NECA with or without MAPK inhibitor against Aβ-induced cognitive deficit and mitochondrial toxicity in the experimental rodents. Further, the effect of NECA with or without MAPK inhibitor was evaluated on Aβ-induced mitochondrial toxicity in the memory-sensitive mice brain regions. Intracerebroventricular (ICV) injection of Aβ 1–42 was injected to healthy male mice through Hamilton syringe via polyethylene tube to induce AD-like behavioral manifestations. NECA attenuated Aβ-induced cognitive impairments in the rodents. In addition, NECA ameliorated Aβ-induced Aβ accumulation and cholinergic dysfunction in the selected memory-sensitive mouse HIP, PFC, and AMY. Further, NECA significantly attenuated Aβ-induced mitochondrial toxicity in terms of decrease in the mitochondrial function, integrity, and bioenergetics in the brain regions of these animals. However, MAPKI diminished the therapeutic effects of NECA on behavioral, biochemical, and molecular observations in AD-like animals. Therefore, it can be speculated that NECA exhibits neuroprotective activity perhaps through MAPK activation in AD-like rodents. Moreover, A2b-mediated MAPK activation could be a promising target in the management of AD.

Ali, T. B., Schleret, T. R., Reilly, B. M., Chen, W. Y., & Abagyan, R. (2015). Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada. PLoS One, 10(12), e0144337. https://doi.org/10.1371/journal.pone.0144337.CrossRefPubMedPubMedCentral

Atkins, C. M., Selcher, J. C., Petraitis, J. J., Trzaskos, J. M., & Sweatt, J. D. (1998). The MAPK cascade is required for mammalian associative learning. Nature Neuroscience, 1(7), 602–609. https://doi.org/10.1038/2836.CrossRefPubMed

Björklund, O., Shang, M., Tonazzini, I., Daré, E., & Fredholm, B. B. (2008). Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. European journal of pharmacology, 596(1–3), 6–13. https://doi.org/10.1016/j.ejphar.2008.08.002.CrossRefPubMed

Chance, B., & Williams, G. (1955). Respiratory enzymes in oxidative phosphorylation. Journal of Biological Chemistry, 217, 409–428.PubMed

Chang, K.-W., Zong, H.-F., Ma, K.-G., Zhai, W.-Y., Yang, W.-N., Hu, X.-D., et al. (2018). Activation of α7 nicotinic acetylcholine receptor alleviates Aβ1-42-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways. Neurochemistry International, 120, 238–250. https://doi.org/10.1016/j.neuint.2018.09.005.CrossRefPubMed

Cheng, C. C., Yang, Y. L., Liao, K. H., & Lai, T. W. (2016). Adenosine receptor agonist NECA increases cerebral extravasation of fluorescein and low molecular weight dextran independent of blood-brain barrier modulation. Scientific Reports, 6, 23882. https://doi.org/10.1038/srep23882.CrossRefPubMedPubMedCentral

Contestabile, A. (2011). The history of the cholinergic hypothesis. Behavioural Brain Research, 221(2), 334–340. https://doi.org/10.1016/j.bbr.2009.12.044.CrossRefPubMed

Daré, E., Schulte, G., Karovic, O., Hammarberg, C., & Fredholm, B. B. (2007). Modulation of glial cell functions by adenosine receptors. Physiology and Behavior, 92(1–2), 15–20. https://doi.org/10.1016/j.physbeh.2007.05.031.CrossRefPubMed

Dong, H., Yuede, C. M., Coughlan, C. A., Murphy, K. M., & Csernansky, J. G. (2009). Effects of donepezil on amyloid-β and synapse density in the Tg2576 mouse model of Alzheimer’s disease. Brain Research, 1303(1), 169–178. https://doi.org/10.1016/j.brainres.2009.09.097.CrossRefPubMedPubMedCentral

Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A. A., Mckhann, G. M., et al. (2008). Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nature Medicine, 14(10), 1097–1105. https://doi.org/10.1038/nm.1868.CrossRefPubMedPubMedCentral

Duarte-Araújo, M., Nascimento, C., Timóteo, M. A., Magalhães-Cardoso, T., & Correia-de-Sá, P. (2004). Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A 2A and extrajunctional inhibitory A 1 receptors. British Journal of Pharmacology, 141(6), 925–934. https://doi.org/10.1038/sj.bjp.0705697.CrossRefPubMedPubMedCentral

Elsherbiny, N. M., Abd El Galil, K. H., Gabr, M. M., Al-Gayyar, M. M., Eissa, L. A., & El-Shishtawy, M. M. (2012). Reno-protective effect of NECA in diabetic nephropathy: Implication of IL-18 and ICAM-1. European Cytokine Network, 23(3), 78–86. https://doi.org/10.1684/ecn.2012.0309.CrossRefPubMed

Gao, Z. G., Inoue, A., & Jacobson, K. A. (2018). On the G protein-coupling selectivity of the native A2B adenosine receptor. Biochemical Pharmacology, 151, 201–213. https://doi.org/10.1016/j.bcp.2017.12.003.CrossRefPubMed

Garabadu, D., & Verma, J. (2019). Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats. Neurochemistry International, 128(April), 39–49. https://doi.org/10.1016/j.neuint.2019.04.006.CrossRefPubMed

Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011). Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration. Biochimica et Biophysica Acta Biomembranes, 1808(5), 1380–1399. https://doi.org/10.1016/j.bbamem.2010.12.001.CrossRef

Goulding, J., May, L. T., & Hill, S. J. (2018). Characterisation of endogenous A_2A and A_2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: evidence for an allosteric mechanism of action for the A_2B-selective antagonist PSB 603. Biochemical Pharmacology, 147, 55–66. https://doi.org/10.1016/j.bcp.2017.10.013.CrossRefPubMedPubMedCentral

Grimaldi, M., Marino, S. D., Florenzano, F., Ciotta, M. T., Nori, S. L., Rodriquez, M., et al. (2016). β-Amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy? Future Medicinal Chemistry, 8(11), 1179–1189. https://doi.org/10.4155/fmc-2016-0006.CrossRefPubMed

Huang, S.-G. (2002). Development of a high throughput screening assay for mitochondrial membrane potential in living cells. Journal of Biomolecular Screening, 7(4), 383–389. https://doi.org/10.1177/1087057108315513.CrossRefPubMed

John, A., Kubosumi, A., & Reddy, P. H. (2020). Mitochondrial MicroRNAs in aging and neurodegenerative diseases. Cells, 9(6), 1345. https://doi.org/10.3390/cells9061345.CrossRefPubMedCentral

Kalashnyk, O., Lykhmus, O., Oliinyk, O., Komisarenko, S., & Skok, M. (2014). α7 Nicotinic acetylcholine receptor-specific antibody stimulates interleukin-6 production in human astrocytes through p38-dependent pathway. International Immunopharmacology, 23(2), 475–479. https://doi.org/10.1016/j.intimp.2014.09.022.CrossRefPubMed

Kamboj, S. S., Kumar, V., Kamboj, A., & Sandhir, R. (2008). Mitochondrial oxidative stress and dysfunction in rat brain induced by carbofuran exposure. Cellular and Molecular Neurobiology, 28(7), 961–969. https://doi.org/10.1007/s10571-008-9270-5.CrossRefPubMed

Karran, E., Mercken, M., & Strooper, B. D. (2011). The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd3505.CrossRefPubMed

Kim, H. Y., Lee, D. K., Chung, B. R., Kim, H. V., & Kim, Y. (2016). Intracerebroventricular injection of amyloid-β peptides in normal mice to acutely induce alzheimer-like cognitive deficits. Journal of Visualized Experiments, 109, e53308. https://doi.org/10.3791/53308.CrossRef

Kim, P., Kang, P., Yoo, H., et al. (2019). Green tea seed oil suppressed Aβ1–42-induced behavioral and cognitive deficit via the Aβ-related Akt pathway. International Journal of Molecular Sciences, 20(8), 1865. https://doi.org/10.3390/ijms20081865.CrossRefPubMedCentral

Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127(6), 1109–1122. https://doi.org/10.1016/j.cell.2006.11.013.CrossRefPubMed

Lee, B., Sur, B., Shim, J., Hahm, D.-H., & Lee, H. (2014). Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats. BMC Complementary and Alternative Medicine, 14(1), 338. https://doi.org/10.1186/1472-6882-14-338.CrossRefPubMedPubMedCentral

Li, M., Meng, Y., Chu, B., Shen, Y., Liu, X., Ding, M., et al. (2020). Orexin-A aggravates cytotoxicity and mitochondrial impairment in SH-SY5Y cells transfected with APPswe via p38 MAPK pathway. Annals of Translational Medicine. https://doi.org/10.21037/atm.2019.11.68.CrossRefPubMedPubMedCentral

Li, Q., Li, P., Hou, D., Zhang, A., Tao, C., Li, X., et al. (2014). EGF enhances ADSCs secretion via ERK and JNK pathways. Cell Biochemistry and Biophysics, 69(1), 189–196. https://doi.org/10.1007/s12013-013-9769-3.CrossRefPubMed

Liu, D., Xiao, B., Han, F., Wang, E., & Shi, Y. (2012). Single-prolonged stress induces apoptosis in dorsal raphe nucleus in the rat model of posttraumatic stress disorder. BMC Psychiatry, 12, 211. https://doi.org/10.1186/1471-244X-12-211.CrossRefPubMedPubMedCentral

Lowry, O. H., Rosebrough, N. J., Farr, A. L., & RandallL, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of biological chemistry, 193(1), 265–275. https://doi.org/10.1016/0922-338X(96)89160-4.CrossRefPubMed

Ma, K. G., Lv, J., Yang, W. N., Chang, K. W., Hu, X. D., Shi, L. L., et al. (2018). The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain. Brain Research Bulletin, 137(September 2017), 41–52. https://doi.org/10.1016/j.brainresbull.2017.11.006.CrossRefPubMed

Moidunny, S., Vinet, J., Wesseling, E., Bijzet, J., Shieh, C. H., van Ijzendoorn, S. C., et al. (2012). Adenosine A 2B receptor-mediated leukemia inhibitory factor release from astrocytes protects cortical neurons against excitotoxicity. Journal of Neuroinflammation, 9(1), 198. https://doi.org/10.1186/1742-2094-9-198.CrossRefPubMedPubMedCentral

Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods, 11, 47–60. https://doi.org/10.1016/0165-0270(84)90007-4.CrossRefPubMed

Mouri, A., Noda, Y., Hara, H., Mizoguchi, H., Tabira, T., & Nabeshima, T. (2007). Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB Journal, 21(9), 2135–2148. https://doi.org/10.1096/fj.06-7685com.CrossRefPubMed

Mustafa, S. J., Morrison, R. R., Teng, B., & Pelleg, A. (2009). Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handbook of Experimental Pharmacology, 193(193), 161–188. https://doi.org/10.1007/978-3-540-89615-9_6.CrossRef

Muthuraju, S., Maiti, P., Solanki, P., Sharma, A. K., Amitabh, Singh, S. B., et al. (2009). Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. Behavioural Brain Research, 203(1), 1–14. https://doi.org/10.1016/j.bbr.2009.03.026.CrossRefPubMed

Oliver, D., & Reddy, P. H. (2019). Dynamics of dynamin-related protein 1 in Alzheimer's disease and other neurodegenerative diseases. Cells, 8(9), 961. https://doi.org/10.3390/cells8090961.CrossRefPubMedCentral

Onyango, I. G. (2018). Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer’s disease. Neural Regeneration Research, 13(1), 19–25. https://doi.org/10.4103/1673-5374.224362.CrossRefPubMedPubMedCentral

Oz, M., Lorke, D. E., Yang, K.-H. S., & Petroianu, G. (2013). On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer’s disease. Current Alzheimer Research, 10(6), 618–630. https://doi.org/10.2174/15672050113109990132.CrossRefPubMed

Patients, C. (2019). Alzheimer’s association 2019. Alzheimer’s disease facts and figures. Alzheimers Dementia, 15(3), 321–87.

Paxinos, G., & Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates Sixth Edition (Vol. 170, pp. 547–612). Cambridge: Elsevier Academic Press.

Pedersen, P. L., Greenawalt, J. W., Reynafarje, B., Hullihen, J., Decker, G. L., Soper, J. W., et al. (1978). Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods in Cell Biology, 20, 411–481. https://doi.org/10.1016/S0091-679X(08)62030-0.CrossRefPubMed

Pinho, C. M., Teixeira, P. F., & Glaser, E. (2014). Mitochondrial import and degradation of amyloid-β peptide. Biochimica et Biophysica Acta (BBA) Bioenergetics, 1837(7), 1069–1074. https://doi.org/10.1016/j.bbabio.2014.02.007.CrossRef

Reddy, P. H. (2008). Mitochondrial medicine for aging and neurodegenerative diseases. Neuromolecular Med, 10(4), 291–315. https://doi.org/10.1007/s12017-008-8044-z.CrossRefPubMedPubMedCentral

Reddy, P. H., & Reddy, T. P. (2011). Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Current Alzheimer Research, 8(4), 393–409. https://doi.org/10.2174/156720511795745401.CrossRefPubMedPubMedCentral

Reddy, P. H., & Beal, M. F. (2008). Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends in Molecular Medicine, 14(2), 45–53. https://doi.org/10.1016/j.molmed.2007.12.002.CrossRefPubMedPubMedCentral

Reddy, P. H. (2011). Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease. Brain Research, 1415, 136–148. https://doi.org/10.1016/j.brainres.2011.07.052.CrossRefPubMedPubMedCentral

Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., et al. (2012). Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochimica et Biophysica Acta, 1822(5), 639–649. https://doi.org/10.1016/j.bbadis.2011.10.011.CrossRefPubMed

Ren, H., Guo, X., Wang, X., & Cui, Z. (2019). Adenosine A2A receptor deficiency prevents p38MAPK activation and apoptosis of mouse hippocampal cells in the chronic hypoxic-hypercapnia model. Bioscience, Biotechnology and Biochemistry, 83(10), 1837–1842. https://doi.org/10.1080/09168451.2019.1627181.CrossRef

Selkoe, D. J., & Schenk, D. (2003). Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annual Review of Pharmacology and Toxicology, 43, 545–584. https://doi.org/10.1146/annurev.pharmtox.43.100901.140248.CrossRefPubMed

Šimić, G., Babić Leko, M., Wray, S., Harrington, C., Delalle, I., Jovanov-Milošević, N., et al. (2016). Tau protein hyperphosphorylation and aggregation in alzheimer’s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules, 6(1), 6. https://doi.org/10.3390/biom6010006.CrossRefPubMedPubMedCentral

Srinivasan, S., & Avadhani, N. G. (2012). Cytochrome c oxidase dysfunction in oxidative stress. Free Radical Biology and Medicine, 53(6), 1252–1263. https://doi.org/10.1016/j.freeradbiomed.2012.07.021.CrossRefPubMed

Stéphan, A., & Phillips, A. G. (2005). A case for a non-transgenic animal model of Alzheimer's disease. Genes Brain Behaviour, 4(3), 157–172. https://doi.org/10.1111/j.1601-183X.2004.00113.x.CrossRef

Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010). The Alzheimer’s disease mitochondrial cascade hypothesis. Journal of Alzheimer’s Disease, 20(s2), S265–S279. https://doi.org/10.3233/JAD-2010-100339.CrossRefPubMed

Tomàs, J., Garcia, N., Lanuza, M. A., Santafé, M. M., Tomàs, M., Nadal, L., et al. (2018). Adenosine receptors in developing and adult mouse neuromuscular junctions and functional links with other metabotropic receptor pathways. Frontiers in Pharmacology, 9, 397. https://doi.org/10.3389/fphar.2018.00397.CrossRefPubMedPubMedCentral

Wang, S., Mims, P. N., Roman, R. J., & Fan, F. (2016). Is beta-amyloid accumulation a cause or consequence of alzheimer’s disease? Journal of Alzheimers Parkinsonism Dementia, 1, 007.

Xing, F., Han, H., He, Y., Zhang, Y., Jing, L., Xu, Z., et al. (2017). Roles of endoplasmic reticulum stress in NECA-induced cardioprotection against Ischemia/Reperfusion injury. Oxidative Medicine and Cellular Longevity, 2017, 1–10. https://doi.org/10.1155/2017/2490501.CrossRef

Yagle, K., Lu, H., Guizzetti, M., Möller, T., & Costa, L. G. (2001). Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol. Glia, 35(2), 111–120. https://doi.org/10.1002/glia.1076.CrossRefPubMed

Yang, X. M., Krieg, T., Cui, L., Downey, J. M., & Cohen, M. V. (2004). NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. Journal of Molecular and Cellular Cardiology, 36(3), 411–421. https://doi.org/10.1016/j.yjmcc.2003.12.008.CrossRefPubMed

Yang, X., Xin, W., Yang, X.-M., Kuno, A., Rich, T. C., Cohen, M. V., et al. (2011). A 2B adenosine receptors inhibit superoxide production from mitochondrial complex I in rabbit cardiomyocytes via a mechanism sensitive to Pertussis toxin. British Journal of Pharmacology, 163(5), 995–1006. https://doi.org/10.1111/j.1476-5381.2011.01288.x.CrossRefPubMedPubMedCentral

Zhou, Y., Zeng, X., Li, G., Yang, Q., Xu, J., Zhang, M., et al. (2019). Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury. British Journal of Pharmacology, 176(13), 2250–2263. https://doi.org/10.1111/bph.14673.CrossRefPubMedPubMedCentral

Zoukhri, D., & Kublin, C. L. (2001). Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren’s syndrome. Investigative Ophthalmology and Visual Science, 42(5), 925–932. https://doi.org/10.1007/978-1-4615-0717-8_144.CrossRefPubMed

Title: 5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice
Authors: Bhupesh Chandra Semwal
Debapriya Garabadu
Publication date: 01-12-2020
Publisher: Springer US
Keywords: Alzheimer's Disease
Alzheimer's Disease
Published in: NeuroMolecular Medicine / Issue 4/2020
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-020-08615-1

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

5-N-ethyl Carboxamidoadenosine Stimulates Adenosine-2b Receptor-Mediated Mitogen-Activated Protein Kinase Pathway to Improve Brain Mitochondrial Function in Amyloid Beta-Induced Cognitive Deficit Mice

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

A Review of Functional Electrical Stimulation Treatment in Spinal Cord Injury

Transcriptomic Heterogeneity of Alzheimer’s Disease Associated with Lipid Genetic Risk

HLA in Alzheimer’s Disease: Genetic Association and Possible Pathogenic Roles

Galuteolin Inhibited Autophagy for Neuroprotection Against Transient Focal Cerebral Ischemia in Rats

Quercetin Ameliorates CFA-Induced Chronic Inflammatory Hyperalgesia via Modulation of ROS-Mediated ERK1/2 Signaling and Inhibition of Spinal Glial Activation In Vivo

CD137 Ligand-CD137 Interaction is Required For Inflammasome-Associated Brain Injury Following Ischemic Stroke